Promis Net Receivables from 2010 to 2026
| 23J Stock | EUR 10.90 2.50 18.66% |
Net Receivables | First Reported 2010-12-31 | Previous Quarter 70.9 K | Current Value 59.1 K | Quarterly Volatility 10.1 K |
Check Promis Neurosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Promis Neurosciences' main balance sheet or income statement drivers, such as Interest Expense of 119.4 K, Selling General Administrative of 4.4 M or Total Revenue of 0.0, as well as many indicators such as . Promis financial statements analysis is a perfect complement when working with Promis Neurosciences Valuation or Volatility modules.
Promis | Net Receivables |
The Net Receivables trend for Promis Neurosciences offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Promis Neurosciences is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Promis Neurosciences' Net Receivables Growth Pattern
Below is the plot of the Net Receivables of Promis Neurosciences over the last few years. It is Promis Neurosciences' Net Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Promis Neurosciences' overall financial position and show how it may be relating to other accounts over time.
| Net Receivables | 10 Years Trend |
|
Net Receivables |
| Timeline |
Promis Net Receivables Regression Statistics
| Arithmetic Mean | 53,828 | |
| Geometric Mean | 52,974 | |
| Coefficient Of Variation | 18.80 | |
| Mean Deviation | 8,792 | |
| Median | 46,285 | |
| Standard Deviation | 10,118 | |
| Sample Variance | 102.4M | |
| Range | 34.6K | |
| R-Value | 0.69 | |
| Mean Square Error | 56.9M | |
| R-Squared | 0.48 | |
| Significance | 0 | |
| Slope | 1,386 | |
| Total Sum of Squares | 1.6B |
Promis Net Receivables History
About Promis Neurosciences Financial Statements
Promis Neurosciences stakeholders use historical fundamental indicators, such as Promis Neurosciences' Net Receivables, to determine how well the company is positioned to perform in the future. Although Promis Neurosciences investors may analyze each financial statement separately, they are all interrelated. For example, changes in Promis Neurosciences' assets and liabilities are reflected in the revenues and expenses on Promis Neurosciences' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Promis Neurosciences. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Receivables | 70.9 K | 59.1 K |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out the analysis of Promis Neurosciences Correlation against competitors. For more detail on how to invest in Promis Stock please use our How to Invest in Promis Neurosciences guide.You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.